BioTrends Releases TreatmentTrends: US Nephrology, an Ongoing ... - PharmaLive.com (press release) PDF Print

And among those aware of Affymax's Hematide, currently in development, interest is high. The IV iron market, on the other hand, is likely to see more ...

read more

 
Share |
Copyright © 2024 Global Dialysis. All Rights Reserved.

Notice: Undefined variable: query in /home/globaldi/public_html/components/com_joomlawatch/class.joomlawatch.db.php on line 129